litlas
Log inCreate account

Brian Claggett

Active 2012–2025

447
Papers
48,261
Citations
109
h-index
398
i10-index

Citations

Citations per year for Brian Claggett1996: 10 citations2003: 3 citations2004: 1 citations2005: 1 citations2008: 3 citations2009: 1 citations2012: 2 citations2013: 3 citations2014: 44 citations2015: 114 citations2016: 203 citations2017: 273 citations2018: 328 citations2019: 1,236 citations2020: 1,833 citations2021: 2,160 citations2022: 2,155 citations2023: 1,983 citations2024: 3,595 citations2025: 2,434 citations2026: 75 citations1997–2002: no citations, so these years are not shown2006–2007: no citations, so these years are not shown2010–2011: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,603 citing papers, 19.9% of this breakdownUnited Kingdom: 1,872 citing papers, 8.1% of this breakdownItaly: 1,432 citing papers, 6.2% of this breakdownChina: 1,290 citing papers, 5.6% of this breakdownGermany: 1,164 citing papers, 5% of this breakdownCanada: 1,102 citing papers, 4.8% of this breakdownNetherlands: 889 citing papers, 3.8% of this breakdownFrance: 803 citing papers, 3.5% of this breakdownSpain: 673 citing papers, 2.9% of this breakdownAustralia: 633 citing papers, 2.7% of this breakdownJapan: 607 citing papers, 2.6% of this breakdownSweden: 600 citing papers, 2.6% of this breakdown
0%19.9%Other 32.3%

Institutions

Fields

  • Medicine86.9%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Neuroscience1.2%
  • Immunology and Microbiology0.8%
  • Engineering0.7%
  • Health Professions0.6%
  • Other3.1%

Topics

  • Heart Failure Treatment and Management10.8%
  • Cardiovascular Function and Risk Factors10.6%
  • Diabetes Treatment and Management7.6%
  • Cardiac pacing and defibrillation studies2.2%
  • Cardiac Imaging and Diagnostics1.7%
  • Pancreatic function and diabetes1.6%
  • Other65.5%

Coauthors

All papers

Open in search
  1. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    Authors: Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde - New England Journal of Medicine 2022 cited by 2,658

  2. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

    Authors: Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz - New England Journal of Medicine 2019 cited by 2,354

  3. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

    Authors: Muthiah Vaduganathan, Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, John J.V. McMurray, Scott D. Solomon - The Lancet 2022 cited by 916

  4. Spironolactone for Heart Failure with Preserved Ejection Fraction

    Authors: Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann, Robin Boineau, Inder S. Anand, Brian Claggett, Nadine Clausell, Akshay S. Desai, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев, Brian Harty, John F. Heitner, Christopher T. Kenwood, Eldrin F. Lewis, Eileen O’Meara, Jeffrey L. Probstfield, Tamaz Shaburishvili, Sanjiv J. Shah, Scott D. Solomon, Nancy K. Sweitzer, Song Yang, Sonja M. McKinlay - New England Journal of Medicine 2014 cited by 2,730

  5. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Authors: Marc A. Pfeffer, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber, Francesca Lawson, Lin Ping, Xiaodan Wei, Eldrin F. Lewis, Aldo P. Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif - New England Journal of Medicine 2015 cited by 2,338

  6. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    Authors: Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Akshay S. Desai, Alasdair D Henderson, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Imran Zainal Abidin, Marco A. Alcocer‐Gamba, J. Atherton, Johann Bauersachs, Changsheng Ma, Chern‐En Chiang, Ovidiu Chioncel, Vijay Chopra, Josep Comin-Colet, Gerasimos Filippatos, Cândida Fonseca, Grzegorz Gajos, Sorel Goland, Eva Gonçalvesová, Seok‐Min Kang, Tzvetana Katova, Mikhail Kosiborod, Gustavs Latkovskis, Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Peter Kolkhof, Prabhakar Viswanathan - New England Journal of Medicine 2024 cited by 709

  7. Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

    Authors: Brendon L. Neuen, Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott, Julianna de Oliveira Costa, Michael O. Falster, Sallie‐Anne Pearson, Kenneth W. Mahaffey, Bruce Neal, Rajiv Agarwal, George L. Bakris, Vlado Perkovic, Scott D. Solomon, Muthiah Vaduganathan - Circulation 2023 cited by 300

  8. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Authors: Marc A. Pfeffer, Brian Claggett, Susan F. Assmann, Robin Boineau, Inder S. Anand, Nadine Clausell, Akshay S. Desai, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев, John F. Heitner, Eldrin F. Lewis, Eileen O’Meara, Jean L. Rouleau, Jeffrey L. Probstfield, Tamaz Shaburishvili, Sanjiv J. Shah, Scott D. Solomon, Nancy K. Sweitzer, Sonja M. McKinlay, Bertram Pitt - Circulation 2014 cited by 1,040

  9. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

    Authors: Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Michael R. Zile, Karl Swedberg, Jean L. Rouleau, Marc A. Pfeffer, Akshay S. Desai, Lars H. Lund, Lars Køber, Inder S. Anand, Nancy K. Sweitzer, Gerard C.M. Linssen, Béla Merkely, Juan Luis Arango, Dragoş Vinereanu, Chen-Huan Chen, Michele Senni, Antonio S. Sibulo, S. А. Boytsov, Victor Shi, Adel R. Rizkala, Martin Lefkowitz, John J.V. McMurray - Circulation 2019 cited by 537

  10. Dapagliflozin for heart failure according to body mass index: the DELIVER trial

    Authors: Carly Adamson, Toru Kondo, Pardeep S. Jhund, Rudolf A. de Boer, Jose Walter Cabrera Honorio, Brian Claggett, Akshay S. Desai, Marco Antonio Alcocer Gamba, Waleed Al Habeeb, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Anna Maria Langkilde, Daniel Lindholm, Erasmus Bachus, Sheldon E. Litwin, Felipe A. Martínez, Magnus Petersson, Sanjiv J. Shah, Muthiah Vaduganathan, Pham Nguyễn Vinh, Ulrica Wilderäng, Scott D. Solomon, John J.V. McMurray - European Heart Journal 2022 cited by 146

  11. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

    Authors: Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Jonathan W. Cunningham, João Pedro Ferreira, Faı̈ez Zannad, Milton Packer, Gregg C. Fonarow, John J.V. McMurray, Scott D. Solomon - The Lancet 2020 cited by 649

  12. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis

    Authors: Sara B. Seidelmann, Brian Claggett, Susan Cheng, Mir Henglin, Amil M. Shah, Lyn M. Steffen, Aaron R. Folsom, Eric B. Rimm, Walter C. Willett, Scott D. Solomon - The Lancet Public Health 2018 cited by 763

  13. Sex Differences in Blood Pressure Trajectories Over the Life Course

    Authors: Hongwei Ji, Andy Kim, Joseph E. Ebinger, Teemu Niiranen, Brian Claggett, C. Noel Bairey Merz, Susan Cheng - JAMA Cardiology 2020 cited by 543

  14. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Authors: Martin S. Maron, Ahmad Masri, Michael E. Nassif, Roberto Barriales‐Villa, Michael Arad, Nuno Cardim, Lubna Choudhury, Brian Claggett, Caroline Coats, Hans‐Dirk Düngen, Pablo García‐Pavía, Albert Hagège, James L. Januzzi, Matthew M.Y. Lee, Gregory D. Lewis, Changsheng Ma, Michelle Michels, Iacopo Olivotto, Artur Oręziak, Anjali Owens, John A. Spertus, Scott D. Solomon, Jacob Tfelt‐Hansen, Marion van Sinttruije, Josef Veselka, Hugh Watkins, Daniel Jacoby, Stephen B. Heitner, Stuart Kupfer, Fady I. Malik, Lisa Meng, Amy Wohltman, Theodore P. Abraham - New England Journal of Medicine 2024 cited by 282

  15. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

    Authors: Pardeep S. Jhund, Toru Kondo, Jawad H. Butt, Kieran F. Docherty, Brian Claggett, Akshay S. Desai, Muthiah Vaduganathan, Samvel B. Gasparyan, Olof Bengtsson, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Lars Køber, Carolyn S.P. Lam, Felipe A. Martínez, Marc S. Sabatine, Sanjiv J. Shah, Scott D. Solomon, John J.V. McMurray - Nature Medicine 2022 cited by 275

  16. Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

    Authors: Marc A. Pfeffer, Brian Claggett, Eldrin F. Lewis, Christopher B. Granger, Lars Køber, Aldo P. Maggioni, Douglas L. Mann, John J.V. McMurray, Jean-Lucien Rouleau, Scott D. Solomon, Philippe G. Steg, Otavio Berwanger, Maja Cikes, Carmine G. De Pasquale, Cara East, Alberto Fernandez, Karola Jering, Ulf Landmesser, Roxana Mehran, Béla Merkely, Freny Vaghaiwalla Mody, Mark C. Petrie, Ivo Petrov, Morten Schou, Michele Senni, David Sim, Peter van der Meer, Martin Lefkowitz, Yinong Zhou, Jianjian Gong, Eugene Braunwald - New England Journal of Medicine 2021 cited by 295

  17. Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

    Authors: Hajime Uno, Brian Claggett, Lü Tian, Eisuke Inoue, Paul Gallo, Toshio Miyata, Deborah Schrag, Masahiro Takeuchi, Yoshiaki Uyama, Lihui Zhao, Hicham Skali, Scott D. Solomon, Susanna Jacobus, Michael Hughes, Milton Packer, L. J. Wei - Journal of Clinical Oncology 2014 cited by 782

  18. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction

    Authors: John J.V. McMurray, Alice M. Jackson, Carolyn S.P. Lam, Margaret M. Redfield, Inder S. Anand, Junbo Ge, Marty Lefkowitz, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Adel R. Rizkala, Shalini V. Sabarwal, Amil M. Shah, Sanjiv J. Shah, Victor Shi, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Maja Čikeš, Eva Gonçalvesová, Tzvetana Katova, Anamaria Kosztin, Małgorzata Lelonek, Nancy K. Sweitzer, Orly Vardeny, Brian Claggett, Pardeep S. Jhund, Scott D. Solomon - Circulation 2019 cited by 370

  19. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

    Authors: Siddharth M. Patel, Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt, Javed Butler, David Z.I. Cherney, Brian Claggett, Robert A. Fletcher, William G. Herrington, Silvio E. Inzucchi, Meg Jardine, Kenneth W. Mahaffey, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Scott D. Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Faı̈ez Zannad, Yujie Zhao, Hiddo J.L. Heerspink, Marc S. Sabatine, Stephen D. Wiviott - Circulation 2024 cited by 165

  20. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

    Authors: Kevin Damman, Mauro Gori, Brian Claggett, Pardeep S. Jhund, Michele Senni, Martin Lefkowitz, Margaret F. Prescott, Victor Shi, Jean L. Rouleau, Karl Swedberg, Michael R. Zile, Milton Packer, Akshay S. Desai, Scott D. Solomon, John J.V. McMurray - JACC Heart Failure 2018 cited by 440

  21. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

    Authors: Jawad H. Butt, Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai, Jarosław Dróżdż, Adrian F. Hernandez, Silvio E. Inzucchi, Tzvetana Katova, Masafumi Kitakaze, Mikhail Kosiborod, Carolyn S.P. Lam, Anna Maria Langkilde, Daniel Lindholm, Erasmus Bachus, Felipe A. Martínez, Béla Merkely, Magnus Petersson, Jose F. Kerr Saraiva, Sanjiv J. Shah, Muthiah Vaduganathan, Orly Vardeny, Ulrica Wilderäng, Brian Claggett, Scott D. Solomon, John J.V. McMurray - Circulation 2022 cited by 150

  22. Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Authors: Finnian R. Mc Causland, Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, Kieran F. Docherty, James C. Fang, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, José Francisco Kerr Saraiva, Martina M. McGrath, Sanjiv J. Shah, Subodh Verma, Anna Maria Langkilde, Magnus Petersson, John J.V. McMurray, Scott D. Solomon - JAMA Cardiology 2022 cited by 122

  23. Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction

    Authors: Elisabeth Kraigher‐Krainer, Amil M. Shah, Deepak K. Gupta, Ângela Barreto Santiago Santos, Brian Claggett, Burkert Pieske, Michael R. Zile, Adriaan A. Voors, Marty Lefkowitz, Milton Packer, John J.V. McMurray, Scott D. Solomon - Journal of the American College of Cardiology 2013 cited by 755

  24. Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial

    Authors: Muthiah Vaduganathan, Brian Claggett, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Akshay S. Desai, Pardeep S. Jhund, Prabhakar Viswanathan, Antonieta Bomfim Wirtz, Patrick Schloemer, James Lay‐Flurrie, John J.V. McMurray, Scott D. Solomon - European Journal of Heart Failure 2024 cited by 80